Director, Pipeline and Portfolio Market Planning
Corcept Therapeutics is hiring for Director, Pipeline and Portfolio Market Planning in Redwood City, California, United States. Executive level, $215k–$270k a year stated. First seen October 31, 2026; open as of November 11, 2026. Jobs taken straight from company career pages — no aggregator in between.
With Destava: How well do you fit? · Tailor my résumé · Write a cover letter
- Company
- Corcept Therapeutics
- Where
- Redwood City, California, United States
- Level
- Executive
- Pay stated
- $215k–$270k a year
- First seen
- October 31, 2026
- Listed via
- Greenhouse
What the posting says
Responsibilities: Drive and influence program-level strategy initiatives to define product vision, optimize lifecycle value, and drive business impact Provide physician, patient, and payer perspective in clinical strategy and new product planning Design, implement, and continuously refine competitive intelligence and market analysis frameworks that proactively inform program decision-making Independently lead integrated cross-functional teams, including Commercial, Medical, Development, and Research, to ensure alignment and strategic continuity across the product lifecycle Develop, maintain,…
Read more and apply on Corcept Therapeutics' site
More jobs like this
Product Marketing Manager, Knowledge Work - Enterprise
Save to applyMartech Operations Lead
Save to applySenior Product Marketing Manager - Lending
Save to applyHead of Growth Marketing
Save to apply
See all 714 Marketing Managers jobs in San Francisco Bay Area
A search agent finds the jobs this list misses: the ones that mean the same without the same words. Have Destava watch for director, pipeline and portfolio market planning jobs in Redwood City, California, United States, new matches every morning on your own account.
This page includes information from the O*NET 31.0 Database by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license. O*NET® is a trademark of USDOL/ETA.